These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
319 related items for PubMed ID: 26858388
21. Research priorities for global measles and rubella control and eradication. Goodson JL, Chu SY, Rota PA, Moss WJ, Featherstone DA, Vijayaraghavan M, Thompson KM, Martin R, Reef S, Strebel PM. Vaccine; 2012 Jul 06; 30(32):4709-16. PubMed ID: 22549089 [Abstract] [Full Text] [Related]
22. [Plan for the Elimination of Measles and Rubella in Spain]. Limia Sánchez A. Rev Esp Salud Publica; 2015 Jul 06; 89(4):393-6. PubMed ID: 26580794 [Abstract] [Full Text] [Related]
23. Perspective on Global Measles Epidemiology and Control and the Role of Novel Vaccination Strategies. Coughlin MM, Beck AS, Bankamp B, Rota PA. Viruses; 2017 Jan 19; 9(1):. PubMed ID: 28106841 [Abstract] [Full Text] [Related]
24. Measles and rubella elimination initiatives in the Americas: lessons learned and best practices. Castillo-Solorzano C, Marsigli C, Danovaro-Holliday MC, Ruiz-Matus C, Tambini G, Andrus JK. J Infect Dis; 2011 Jul 19; 204 Suppl 1():S279-83. PubMed ID: 21666173 [Abstract] [Full Text] [Related]
25. [Progress in the elimination of measles and rubella in the WHO European Region]. Muscat M, Jankovic D, Goel A, Butler R, Pfeifer D. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Sep 19; 56(9):1225-30. PubMed ID: 23990083 [Abstract] [Full Text] [Related]
26. Progress toward measles and rubella elimination in Egypt. El Sayed N, Kandeel N, Barakat I, Moussa I, Alexander JP, Naouri B, Reef SE. J Infect Dis; 2011 Jul 19; 204 Suppl 1():S318-24. PubMed ID: 21666180 [Abstract] [Full Text] [Related]
27. Nationwide campaign for vaccination of adults against rubella and measles--Costa Rica, 2001. Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep; 2001 Nov 09; 50(44):976-9. PubMed ID: 11724151 [Abstract] [Full Text] [Related]
28. Global Measles and Rubella Laboratory Network, January 2004-June 2005. Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep; 2005 Nov 04; 54(43):1100-4. PubMed ID: 16267497 [Abstract] [Full Text] [Related]
29. Innovations in vaccine delivery: increasing access, coverage, and equity and lessons learnt from measles and rubella elimination. Goodson JL, Rota PA. Drug Deliv Transl Res; 2022 May 04; 12(5):959-967. PubMed ID: 35211868 [Abstract] [Full Text] [Related]
30. Progress in measles and rubella elimination in Iran. Esteghamati A, Gouya MM, Zahraei SM, Dadras MN, Rashidi A, Mahoney F. Pediatr Infect Dis J; 2007 Dec 04; 26(12):1137-41. PubMed ID: 18043452 [Abstract] [Full Text] [Related]
31. Accelerated rubella control and congenital rubella syndrome prevention strengthen measles eradication: the Costa Rican experience. Morice A, Carvajal X, León M, Machado V, Badilla X, Reef S, Lievano F, Depetris A, Castillo-Solórzano C. J Infect Dis; 2003 May 15; 187 Suppl 1():S158-63. PubMed ID: 12721908 [Abstract] [Full Text] [Related]
32. Haiti 2007-2008 national measles-rubella vaccination campaign: implications for rubella elimination. Rainey JJ, Danovaro-Holliday MC, Magloire R, Kananda G, Lee CE, Chamouillet H, Lacapere F, Mung K, Luman ET. J Infect Dis; 2011 Sep 01; 204 Suppl 2():S616-21. PubMed ID: 21954256 [Abstract] [Full Text] [Related]
33. [The elimination of measles and rubella in Italy]. Adamo G, Sturabotti G, De Soccio P, Prencipe GP, Sciarra I, Baccolini V, Massimi A, Marzuillo C, Iannazzo S, Villari P. Ig Sanita Pubbl; 2017 Sep 01; 73(5):429-442. PubMed ID: 29433130 [Abstract] [Full Text] [Related]
34. Modeling and Managing the Risks of Measles and Rubella: A Global Perspective Part II. Thompson KM. Risk Anal; 2017 Jun 01; 37(6):1041-1051. PubMed ID: 28471528 [Abstract] [Full Text] [Related]
35. Toward rubella elimination in Poland: need for supplemental immunization activities, enhanced surveillance, and further integration with measles elimination efforts. Zimmerman L, Rogalska J, Wannemuehler KA, Haponiuk M, Kosek A, Pauch E, Plonska E, Veltze D, Czarkowski MP, Buddh N, Reef S, Stefanoff P. J Infect Dis; 2011 Jul 01; 204 Suppl 1():S389-95. PubMed ID: 21666189 [Abstract] [Full Text] [Related]
36. Feasibility assessment of measles and rubella eradication. Moss WJ, Shendale S, Lindstrand A, O'Brien KL, Turner N, Goodman T, Kretsinger K, SAGE Working Group on Measles and Rubella Vaccines, Measles and Rubella Eradication Feasibility Assessment Workshop Participants. Vaccine; 2021 Jun 16; 39(27):3544-3559. PubMed ID: 34045102 [Abstract] [Full Text] [Related]
37. Expansion of Vaccination Services and Strengthening Vaccine-Preventable Diseases Surveillance in Haiti, 2010-2016. Tohme RA, Francois J, Cavallaro KF, Paluku G, Yalcouye I, Jackson E, Wright T, Adrien P, Katz MA, Hyde TB, Faye P, Kimanuka F, Dietz V, Vertefeuille J, Lowrance D, Dahl B, Patel R. Am J Trop Med Hyg; 2017 Oct 16; 97(4_Suppl):28-36. PubMed ID: 29064356 [Abstract] [Full Text] [Related]
38. Eradicating Measles: A Call for an Exceptional Coordinated Global Effort. Durrheim DN, Andrus JK, Pfaff G, Tabassum S, Bashour H, Githanga D. J Infect Dis; 2019 Nov 06; 220(12):1870-1872. PubMed ID: 30615164 [Abstract] [Full Text] [Related]
39. Accelerating measles and rubella elimination through research and innovation - Findings from the Measles & Rubella Initiative research prioritization process, 2016. Grant GB, Masresha BG, Moss WJ, Mulders MN, Rota PA, Omer SB, Shefer A, Kriss JL, Hanson M, Durrheim DN, Linkins R, Goodson JL. Vaccine; 2019 Sep 10; 37(38):5754-5761. PubMed ID: 30904317 [Abstract] [Full Text] [Related]